These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 15150205)

  • 21. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and predictors of recurrent sick leave in survivors who returned to work after allogeneic hematopoietic cell transplantation.
    Kurosawa S; Yamaguchi T; Mori A; Matsuura T; Masuko M; Murata M; Tashiro H; Kako S; Satake A; Hagihara M; Ota S; Saito T; Kagawa K; Matsuo Y; Itonaga H; Uoshima N; Yamaguchi H; Naito K; Takahashi M; Fukuda T
    J Cancer Surviv; 2023 Jun; 17(3):781-794. PubMed ID: 36048313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of immune status and hematopoietic recovery before and after fludarabine, IV busulfan, and antithymocyte globulins (FB2 regimen) reduced-intensity conditioning regimen (RIC) allogeneic stem cell transplantation (allo-SCT).
    Le Bourgeois A; Lestang E; Guillaume T; Delaunay J; Ayari S; Blin N; Clavert A; Tessoulin B; Dubruille V; Mahe B; Roland V; Gastinne T; Le Gouill S; Moreau P; Mohty M; Planche L; Chevallier P
    Eur J Haematol; 2013 Mar; 90(3):177-86. PubMed ID: 23301689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlates of anxiety and depression symptoms among patients and their family caregivers prior to allogeneic hematopoietic cell transplant for hematological malignancies.
    Posluszny DM; Bovbjerg DH; Syrjala KL; Agha M; Dew MA
    Support Care Cancer; 2019 Feb; 27(2):591-600. PubMed ID: 30022348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
    Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation.
    Farina L; Bruno B; Patriarca F; Spina F; Sorasio R; Morelli M; Fanin R; Boccadoro M; Corradini P
    Leukemia; 2009 Jun; 23(6):1131-8. PubMed ID: 19194465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance limitations and participation restrictions among childhood cancer survivors treated with hematopoietic stem cell transplantation: the bone marrow transplant survivor study.
    Ness KK; Bhatia S; Baker KS; Francisco L; Carter A; Forman SJ; Robison LL; Rosenthal J; Gurney JG
    Arch Pediatr Adolesc Med; 2005 Aug; 159(8):706-13. PubMed ID: 16061776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls.
    Bishop MM; Beaumont JL; Hahn EA; Cella D; Andrykowski MA; Brady MJ; Horowitz MM; Sobocinski KA; Rizzo JD; Wingard JR
    J Clin Oncol; 2007 Apr; 25(11):1403-11. PubMed ID: 17416860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the hematopoietic cell transplantation specific comorbidity index (HCT-CI) predict transplantation outcomes? A prospective multicenter validation study of the Kanto Study Group for Cell Therapy.
    Nakaya A; Mori T; Tanaka M; Tomita N; Nakaseko C; Yano S; Fujisawa S; Sakamaki H; Aotsuka N; Yokota A; Kanda Y; Sakura T; Nanya Y; Saitoh T; Kanamori H; Takahashi S; Okamoto S
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1553-9. PubMed ID: 25034961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Phase II Trial of Fludarabine/Melphalan 100 Conditioning Therapy Followed by Allogeneic Hematopoietic Cell Transplantation for Patients With Lymphoma.
    Lee JH; Lee JH; Kim DY; Seol M; Lee YS; Kang YA; Jeon M; Lee KH
    Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):655-63. PubMed ID: 26428486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience.
    Omer AK; Ziakas PD; Anagnostou T; Coughlin E; Kourkoumpetis T; McAfee SL; Dey BR; Attar E; Chen YB; Spitzer TR; Mylonakis E; Ballen KK
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1190-6. PubMed ID: 23747459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies.
    Naik S; Martinez C; Leung K; Sasa G; Nguyen NY; Wu MF; Gottschalk S; Brenner M; Heslop H; Krance R
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1266-72. PubMed ID: 25765555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of biomedical and psychosocial factors for the prediction of pain and distress in patients undergoing high-dose therapy and BMT/PBSCT.
    Schulz-Kindermann F; Hennings U; Ramm G; Zander AR; Hasenbring M
    Bone Marrow Transplant; 2002 Feb; 29(4):341-51. PubMed ID: 11896432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34+ cells from a third-party donor: results of a multicenter study from the Grupo Español de Trasplante Hematopoyético (GETH).
    Martino R; Bautista G; Parody R; García I; Esquirol A; Rovira M; Cabrera JR; Regidor C; Fores R; García-Marco JA; Serrano D; Barba P; Heras I; Marquez-Malaver FJ; Sánchez-Ortega I; Duarte R; Saavedra S; Sierra J; Vazquez L;
    Transpl Infect Dis; 2015 Apr; 17(2):221-33. PubMed ID: 25652036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
    Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI
    Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year?
    Hjermstad M; Holte H; Evensen S; Fayers P; Kaasa S
    Bone Marrow Transplant; 1999 Oct; 24(8):911-8. PubMed ID: 10516705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation.
    El-Jawahri AR; Traeger LN; Kuzmuk K; Eusebio JR; Vandusen HB; Shin JA; Keenan T; Gallagher ER; Greer JA; Pirl WF; Jackson VA; Ballen KK; Spitzer TR; Graubert TA; McAfee SL; Dey BR; Chen YB; Temel JS
    Cancer; 2015 Mar; 121(6):951-9. PubMed ID: 25469752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of graft-versus-host disease on allogeneic hematopoietic cell transplantation for adult T cell leukemia-lymphoma focusing on preconditioning regimens: nationwide retrospective study.
    Ishida T; Hishizawa M; Kato K; Tanosaki R; Fukuda T; Takatsuka Y; Eto T; Miyazaki Y; Hidaka M; Uike N; Miyamoto T; Tsudo M; Sakamaki H; Morishima Y; Suzuki R; Utsunomiya A
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1731-9. PubMed ID: 24090597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developing a Risk Prediction Model for Long-Term Physical and Psychological Functioning after Hematopoietic Cell Transplantation.
    Braamse AM; Yi JC; Visser OJ; Heymans MW; van Meijel B; Dekker J; Syrjala KL
    Biol Blood Marrow Transplant; 2016 Mar; 22(3):549-56. PubMed ID: 26685773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.